Companion Diagnostics Guidance Finalized, But Lab Test Enforcement To Be Key

FDA makes very few revisions from its three-year-old draft, but simultaneously releases the much-delayed proposal to begin actively regulating lab-developed tests, which presents important underlying questions for personalized medicine.

More from United States

More from North America